PL366836A1 - Antibacterial agent - Google Patents

Antibacterial agent

Info

Publication number
PL366836A1
PL366836A1 PL02366836A PL36683602A PL366836A1 PL 366836 A1 PL366836 A1 PL 366836A1 PL 02366836 A PL02366836 A PL 02366836A PL 36683602 A PL36683602 A PL 36683602A PL 366836 A1 PL366836 A1 PL 366836A1
Authority
PL
Poland
Prior art keywords
antibacterial agent
antibacterial
agent
Prior art date
Application number
PL02366836A
Other languages
English (en)
Polish (pl)
Inventor
Frank Mayer
Original Assignee
Novologix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10129870A external-priority patent/DE10129870A1/de
Application filed by Novologix Gmbh filed Critical Novologix Gmbh
Publication of PL366836A1 publication Critical patent/PL366836A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL02366836A 2001-04-30 2002-04-22 Antibacterial agent PL366836A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10121145 2001-04-30
DE10129870A DE10129870A1 (de) 2001-04-30 2001-06-21 Antibakterielles Mittel

Publications (1)

Publication Number Publication Date
PL366836A1 true PL366836A1 (en) 2005-02-07

Family

ID=26009202

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366836A PL366836A1 (en) 2001-04-30 2002-04-22 Antibacterial agent

Country Status (17)

Country Link
EP (1) EP1397157A2 (zh)
JP (1) JP2004534016A (zh)
CN (1) CN1298739C (zh)
AU (1) AU2002302555B2 (zh)
BG (1) BG108399A (zh)
BR (1) BR0209282A (zh)
CA (1) CA2445995A1 (zh)
CZ (1) CZ20033271A3 (zh)
EE (1) EE200300530A (zh)
HU (1) HUP0401586A3 (zh)
IL (1) IL158627A0 (zh)
MX (1) MXPA03009954A (zh)
NZ (1) NZ529662A (zh)
PL (1) PL366836A1 (zh)
RU (1) RU2003134636A (zh)
SK (1) SK14792003A3 (zh)
WO (1) WO2002087554A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229645A1 (de) * 2002-07-02 2004-05-19 Kuchenreuther, Ulrich, Dr. Zellaufschluss von Bakterien
PT2459176T (pt) 2009-07-31 2017-12-11 Gruenenthal Gmbh Método de cristalização e biodisponibilidade
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
CN105218668B (zh) * 2015-10-30 2020-03-24 山东农业大学 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466251A1 (en) * 1990-07-10 1992-01-15 Gist-Brocades N.V. Elfamycin-resistant mutants
ES2275336T3 (es) * 1998-01-23 2007-06-01 Biomerieux B.V. Arnm del ef-tu para determinar la viabilidad de bacterias.
US6451556B1 (en) * 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu

Also Published As

Publication number Publication date
AU2002302555B2 (en) 2007-08-23
CZ20033271A3 (en) 2004-06-16
WO2002087554B1 (de) 2005-01-27
BG108399A (bg) 2004-08-31
HUP0401586A2 (hu) 2004-11-29
WO2002087554A2 (de) 2002-11-07
CN1298739C (zh) 2007-02-07
EP1397157A2 (de) 2004-03-17
CN1518455A (zh) 2004-08-04
HUP0401586A3 (en) 2005-06-28
WO2002087554A3 (de) 2003-01-30
EE200300530A (et) 2004-04-15
IL158627A0 (en) 2004-05-12
JP2004534016A (ja) 2004-11-11
BR0209282A (pt) 2004-07-27
MXPA03009954A (es) 2005-07-25
SK14792003A3 (sk) 2004-07-07
NZ529662A (en) 2006-08-31
RU2003134636A (ru) 2005-04-20
CA2445995A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
GB0302415D0 (en) Antimicrobial agent
AU2003300965A8 (en) Antibacterial agents
HK1079506A1 (en) Antibacterial mutilins
HK1061856A1 (en) Antimicrobial compounds
EP1366664A4 (en) ANTIBACTERIAL COMPOSITION
AU2003224345A8 (en) Antibacterial agents
GB0229673D0 (en) Antibacterial agents
HUP0401586A3 (en) Antibacterial agent
GB0208579D0 (en) Antibacterial agents
GB0106428D0 (en) Antibacterial composition
GB0122162D0 (en) Agent
GB0106987D0 (en) Immunotherapeuitic agent
GB0223532D0 (en) Antibacterial agents
GB0100949D0 (en) Antibacterial agents
GB0102641D0 (en) Antibacterial agents
GB0110705D0 (en) Antibacterial Agents
GB0115197D0 (en) Antibacterial Agents
GB0123792D0 (en) Antibacterial agents
GB0228365D0 (en) Antibacterial agents
GB0204703D0 (en) Antibacterial agent
GB0128234D0 (en) Antimicrobial agents
GB0116864D0 (en) Antimicrobial agents
GB0106487D0 (en) Agent
GB0105442D0 (en) Antibacterial compounds
GB0008844D0 (en) Antimicrobial agent